highly significantP < 0.01
The between-cluster analysis consistently showed highly significant differences ( P < 0.01), except for one of the scores measuring polyneuropathy (Neuropathy Disability Score; P = 0.609) and Levodopa dosage ( P = 0.226).
The between-cluster analysis consistently showed highly significant differences ( P < 0.01), except for one of the scores measuring polyneuropathy (Neuropathy Disability Score; P = 0.609) and Levodopa dosage ( P = 0.226).